MENU
MHIG
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

MHIG stock forecast, quote, news & analysis

The investment seeks to generate returns (before Fund fees and expenses) that generally correlate with the healthcare costs for an individual utilizing an employer-provided health plan in the United States (“U... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for MHIG with price predictions
Nov 05, 2026

MHIG in upward trend: price rose above 50-day moving average on October 28, 2026

MHIG moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 2 of 2 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on MHIG as a result. In 3 of 4 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

The Moving Average Convergence Divergence (MACD) for MHIG just turned positive on October 15, 2026. Looking at past instances where MHIG's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.

The 10-day moving average for MHIG crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to generate returns (before Fund fees and expenses) that generally correlate with the healthcare costs for an individual utilizing an employer-provided health plan in the United States (“U.S. Healthcare Cost Inflation”). The common stocks in which the fund primarily invests are those issued by companies in the U.S. healthcare sector and sectors that comprise the supply chain for the U.S. healthcare sector, and include companies of all capitalization sizes. Milliman determines the common stock portfolio weight by implementing a factor approach. The fund is non-diversified.

Market Cap

The average market capitalization across the Milliman Healthcare Inflation Guard ETF (MHIG) ETF is 133.13B. The market cap for tickers in the group ranges from 8.49B to 1.22T. LLY holds the highest valuation in this group at 1.22T. The lowest valued company is IBRX at 8.49B.

High and low price notable news

The average weekly price growth across all stocks in the Milliman Healthcare Inflation Guard ETF (MHIG) ETF was 23%. For the same ETF, the average monthly price growth was 36%, and the average quarterly price growth was 390%. MDLN experienced the highest price growth at 24%, while ILMN experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Milliman Healthcare Inflation Guard ETF (MHIG) ETF was 24%. For the same stocks of the ETF, the average monthly volume growth was 27% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 47
Price Growth Rating: 26
SMR Rating: 62
Profit Risk Rating: 60
Seasonality Score: 19 (-100 ... +100)
MHIG in upward trend: price rose above 50-day moving average on October 28, 2026